Pseudoginsenoside Rh2CAS# 1370264-16-6 |
| Cas No. | 1370264-16-6 | SDF | File under preparation. |
| PubChem ID | 101887368 | Appearance | Powder |
| Formula | C36H62O8 | M.Wt | 622.9 |
| Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(E)-6-hydroxy-6-methylhept-2-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol | ||
| SMILES | CC(=CCCC(C)(C)O)C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C | ||
| Standard InChIKey | YCDZBVXSGVWFFX-AZEZESTHSA-N | ||
| Standard InChI | InChI=1S/C36H62O8/c1-20(10-9-14-32(2,3)42)21-11-16-36(8)27(21)22(38)18-25-34(6)15-13-26(33(4,5)24(34)12-17-35(25,36)7)44-31-30(41)29(40)28(39)23(19-37)43-31/h10,21-31,37-42H,9,11-19H2,1-8H3/b20-10+/t21-,22-,23-,24+,25-,26+,27+,28-,29+,30-,31+,34+,35-,36-/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
The roots of Panax ginseng C. A. Mey.
| Description | 1. Pseudoginsenoside Rh2 has cytotoxicity, it induces mitochondrial apoptosis in A549 cells and is responsible for excessive activation of the Ras/Raf/ERK/p53 pathway. 2. (20Z) -Pseudoginsenoside Rh2 and (20E)-Pseudoginsenoside Rh2 have antioxidative activity. |
| Targets | Raf | ERK | p53 | Bcl-2/Bax | Caspase | PARP |
Pseudoginsenoside Rh2 Dilution Calculator
Pseudoginsenoside Rh2 Molarity Calculator
Similar Structures
-
Pseudoginsenoside Rg3(E)Catalog No.: BCX0849CAS No.: 1012886-99-5 -
Ginsenoside Rh3Catalog No.: BCN1071CAS No.: 105558-26-7 -
Isoginsenoside Rh3Catalog No.: BCN8581CAS No.: 166040-90-0 -
20(R)-Ginsenoside Rh2Catalog No.: BCN2484CAS No.: 112246-15-8 -
20(S)-Ginsenoside Rh2Catalog No.: BCN1070CAS No.: 78214-33-2 -
Ginsenoside Rg5Catalog No.: BCN3551CAS No.: 186763-78-0 -
Pseudoginsenoside Rh1Catalog No.: BCX1076CAS No.: 97744-96-2 -
Ginsenoside F2Catalog No.: BCN1245CAS No.: 62025-49-4 -
Ginsenoside Rk2Catalog No.: BCN3721CAS No.: 364779-14-6 -
20(R)-Ginsenoside Rg3Catalog No.: BCN5018CAS No.: 38243-03-7 -
Ginsenoside Rg3Catalog No.: BCN1068CAS No.: 14197-60-5 -
Gypenoside XVIICatalog No.: BCN2339CAS No.: 80321-69-3 -
Notoginsenoside FeCatalog No.: BCN3852CAS No.: 88105-29-7 -
Ginsenoside Rk1Catalog No.: BCN3552CAS No.: 494753-69-4 -
Ginsenoside Rs3Catalog No.: BCN3716CAS No.: 194861-70-6 -
Ginsenoside Rb1Catalog No.: BCN1063CAS No.: 41753-43-9 -
Ginsenoside RcCatalog No.: BCN1072CAS No.: 11021-14-0 -
StevenleafCatalog No.: BCN5978CAS No.: 80321-63-7 -
Ginsenoside Rd2Catalog No.: BCN8279CAS No.: 83480-64-2 -
Notoginsenoside Ft1Catalog No.: BCN6434CAS No.: 155683-00-4 -
Pseudoginsenoside RC1Catalog No.: BCX1331CAS No.: 102805-32-3 -
Vinaginsenoside R7Catalog No.: BCX1594CAS No.: 156009-83-5 -
Ginsenoside Rb2Catalog No.: BCN1064CAS No.: 11021-13-9 -
Notoginsenoside R4Catalog No.: BCN8834CAS No.: 87741-77-3 -
Ginsenoside Compound KCatalog No.: BCN1246CAS No.: 39262-14-1 -
Ginsenoside Ra2Catalog No.: BCN8555CAS No.: 83459-42-1 -
Quinquenoside R1Catalog No.: BCX0684CAS No.: 85013-02-1 -
Ginsenoside Rs2Catalog No.: BCX2528CAS No.: 87733-66-2
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.6054 mL | 8.027 mL | 16.0539 mL | 32.1079 mL | 40.1349 mL |
| 5 mM | 0.3211 mL | 1.6054 mL | 3.2108 mL | 6.4216 mL | 8.027 mL |
| 10 mM | 0.1605 mL | 0.8027 mL | 1.6054 mL | 3.2108 mL | 4.0135 mL |
| 50 mM | 0.0321 mL | 0.1605 mL | 0.3211 mL | 0.6422 mL | 0.8027 mL |
| 100 mM | 0.0161 mL | 0.0803 mL | 0.1605 mL | 0.3211 mL | 0.4013 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Featured Products
- PRT062607 Hydrochloride
Catalog No.:BCC1869
CAS No.:1370261-97-4
- 3',4'-Di-O-acetyl-2',6'-di-O-p-coumaroylastragalin
Catalog No.:BCN6610
CAS No.:137018-33-8
- Amprolium HCl
Catalog No.:BCC4626
CAS No.:137-88-2
- L-Ascorbyl 6-palmitate
Catalog No.:BCC4915
CAS No.:137-66-6
- Lidocaine
Catalog No.:BCC1084
CAS No.:137-58-6
- Calcium pantothenate
Catalog No.:BCN8503
CAS No.:137-08-6
- Sophoraflavanone I
Catalog No.:BCN6863
CAS No.:136997-69-8
- Sophoraflavanone H
Catalog No.:BCN6864
CAS No.:136997-68-7
- (-)-Syringaresnol-4-O-beta-D-apiofuranosyl-(1->2)-beta-D-glucopyranoside
Catalog No.:BCN1578
CAS No.:136997-64-3
- AHU-377 hemicalcium salt
Catalog No.:BCC5141
CAS No.:1369773-39-6
- Macranthoidin B
Catalog No.:BCN5938
CAS No.:136849-88-2
- TOTU
Catalog No.:BCC2826
CAS No.:136849-72-4
New Products
- Episyringaresinol 4'-O-β-D-glncopyranoside
Catalog No.:BCC8957
CAS No.:137038-13-2
- Walsuralactam A
Catalog No.:BCN6734
CAS No.:1370556-82-3
- PACAP 1-38
Catalog No.:BCC6962
CAS No.:137061-48-4
- Alprenolol hydrochloride
Catalog No.:BCC7490
CAS No.:13707-88-5
- Pimecrolimus
Catalog No.:BCC4703
CAS No.:137071-32-0
- Tolfenamic Acid
Catalog No.:BCC4438
CAS No.:13710-19-5
- (±)-Marmesin
Catalog No.:BCN3618
CAS No.:13710-70-8
- BETP
Catalog No.:BCC6286
CAS No.:1371569-69-5
- Toddalosin
Catalog No.:BCN6194
CAS No.:137182-37-7
- Spinorphin
Catalog No.:BCC2349
CAS No.:137201-62-8
- Sodium Orthovanadate
Catalog No.:BCC3856
CAS No.:13721-39-6
- Voriconazole
Catalog No.:BCC2275
CAS No.:137234-62-9
Pseudoginsenoside Rh2, synthesized from Ginsenoside Rh2, possesses anti-cancer activitied.
Pseudoginsenoside Rh2 (CAS 1370264-16-6) is a natural product offered by BioCrick for research applications. Customers can buy or order Pseudoginsenoside Rh2 from BioCrick, a supplier and manufacturer of research chemicals, with product specifications, purity, packaging, and pricing information available upon request.
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
